Markets:

Overview

News

Currencies

International

Treasuries

Charles River Laboratories International, Inc. Common Stock (NY:CRL)

215.93 -3.60 (-1.64%)

Streaming Delayed Price Updated: 12:58 PM EST, Jan 28, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Charles River Laboratories International, Inc. Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

19 20 Next >

Masimo, Integra LifeSciences, CONMED, IQVIA, and Charles River Laboratories Shares Are Soaring, What You Need To Know

September 30, 2025

A number of stocks jumped in the afternoon session after reports revealed a potential drug-pricing agreement between the White House and the pharmaceutical industry. The Trump administration is...

Via StockStory

Topics Government World Trade

What's going on in today's session: S&P500 movers ↗

September 30, 2025

Stay informed about the performance of the S&P500 index one hour before the close of the markets on Tuesday. Uncover the top gainers and losers in today's session for valuable insights.

Via Chartmill

Earnings Scheduled For August 6, 2025 ↗

August 06, 2025

Via Benzinga

Mr Wonderful Kevin O'Leary Says Bitcoin, Ethereum Enough To 'Capture The Promise' Of Crypto, Advises Against 'Irrelevant' Tokens ↗

September 18, 2025

Renowned investor Kevin O’Leary expressed his belief on Wednesday that owning only Bitcoin (CRYPTO: BTC) and Ethereum (CRYPTO: ETH) can capture the majority of the cryptocurrency market’s volat

Via Benzinga

Charles River Laboratories Announces Chief Financial Officer Transition

September 16, 2025

From Charles River Laboratories International, Inc.

Via Business Wire

Uncover the latest developments among S&P500 stocks in today's session. ↗

September 12, 2025

Curious about the top performers within the S&P500 index one hour before the close of the markets on Friday? Dive into the list of today's session's top gainers and losers for a comprehensive...

Via Chartmill

Exploring the top movers within the S&P500 index during today's session. ↗

September 12, 2025

Stay informed about the performance of the S&P500 index in the middle of the day on Friday. Uncover the top gainers and losers in today's session for valuable insights.

Via Chartmill

Charles River Collaborates to Enhance Oncology Manufacturing Portfolio, Advancing Research and Development of Cell and Gene Therapies to Treat Cancer

September 11, 2025

From Charles River Laboratories International, Inc.

Via Business Wire

3 Unpopular Stocks That Concern Us

September 11, 2025

When Wall Street turns bearish on a stock, it’s worth paying attention. These calls stand out because analysts rarely issue grim ratings on companies for fear their firms will lose out in other...

Via StockStory

Breaking Down Charles River: 6 Analysts Share Their Views ↗

September 09, 2025

Via Benzinga

This Thomson Reuters Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday ↗

September 09, 2025

Via Benzinga

2 Cash-Producing Stocks Worth Your Attention and 1 We Brush Off

September 09, 2025

While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient spending, slowing demand, or weak...

Via StockStory

Charles River Laboratories to Present at Baird and Morgan Stanley Conferences

September 08, 2025

From Charles River Laboratories International, Inc.

Via Business Wire

1 S&P 500 Stock with Exciting Potential and 2 We Brush Off

September 05, 2025

The S&P 500 (^GSPC) is often seen as a benchmark for strong businesses, but that doesn’t mean every stock is worth owning. Some companies face significant challenges, whether it’s stagnating growth,...

Via StockStory

Topics Stocks

Charles River Enhances Cell Therapy Flex Platform through Collaboration with Akadeum Life Sciences

September 03, 2025

From Charles River Laboratories International, Inc.

Via Business Wire

Charles River Joins EASYGEN Consortium, Supports Development of Bedside CAR-T Manufacturing

August 26, 2025

From Charles River Laboratories International, Inc.

Via Business Wire

These S&P500 stocks are gapping in today's session ↗

August 21, 2025

Curious about the market action on Thursday? Dive into the US markets to explore the gap up and gap down stocks in the S&P500 index during today's session.

Via Chartmill

Is the Market Bullish or Bearish on Charles River? ↗

August 15, 2025

Via Benzinga

1 Profitable Stock with Promising Prospects and 2 We Find Risky

August 15, 2025

Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today doesn’t mean it will thrive tomorrow.

Via StockStory

Peter Thiel-Backed Bullish Shoots Up 11% After-Hours Following Blockbuster IPO ↗

August 13, 2025

Shares of cryptocurrency exchange Bullish soared over 11% in Wednesday's after-hours trading following the company's successful Wall Street debut.

Via Benzinga

In today's session, there are S&P500 stocks with remarkable trading volume. ↗

August 13, 2025

Let's have a look at the S&P500 stocks with an unusual volume in today's session.

Via Chartmill

Centene, RadNet, Evolent Health, Illumina, and Charles River Laboratories Shares Are Soaring, What You Need To Know

August 12, 2025

A number of stocks jumped in the morning session after positive inflation data fueled hopes for an interest rate cut by the Federal Reserve.

Via StockStory

Topics Bonds Economy Stocks

CRL Q2 Deep Dive: Flat Sales and Margin Pressures Offset by Demand Stabilization and Raised Outlook

August 12, 2025

Lab services company Charles River Laboratories (NYSE:CRL) reported Q2 CY2025 results topping the market’s revenue expectations, but sales were flat year on year at $1.03 billion. Its non-GAAP profit...

Via StockStory

Topics World Trade

Charles River (CRL) Q2 EPS Jumps 11% ↗

August 06, 2025

Via The Motley Fool

Charles River Sees Limited Impact From NIH Cuts, Tariffs, Drug Pricing ↗

August 06, 2025

Charles River lifts earnings guidance after Q2 beat, citing biotech demand stability, solid DSA performance, and easing regulatory headwinds.

Via Benzinga

Which S&P500 stocks are moving on Wednesday? ↗

August 06, 2025

Let's have a look at what is happening on the US markets in the middle of the day on Wednesday. Below you can find the top S&P500 gainers and losers in today's session.

Via Chartmill

Charles River Laboratories (NYSE:CRL) Delivers Impressive Q2

August 06, 2025

Lab services company Charles River Laboratories (NYSE:CRL) reported Q2 CY2025 results beating Wall Street’s revenue expectations, but sales were flat year on year at $1.03 billion. Its non-GAAP profit...

Via StockStory

Charles River Laboratories Announces Second-Quarter 2025 Results

August 06, 2025

From Charles River Laboratories International, Inc.

Via Business Wire

Charles River Laboratories (CRL) Reports Earnings Tomorrow: What To Expect

August 04, 2025

Lab services company Charles River Laboratories (NYSE:CRL) will be announcing earnings results this Wednesday before market open. Here’s what to look for.

Via StockStory

Charles River and BioTech Social Inc. Pursue Crowdfunding Partnership

July 31, 2025

From Charles River Laboratories International, Inc.

Via Business Wire

< Previous 1 2 3 4 5 6 7 8 9

...

19 20 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.